Author

Loretta M. Amico

Observed name: L.M. Amico

Institution: Bucci Laser Vision Institute

Observed institutions: Bucci Laser Vision Institute, Association for Research in Vision and Ophthalmology

OpenAlex ID: A5083126285

Prostaglandin E2 Inhibition and Aqueous Concentration of Ketorolac 0.4% (Acular LS) and Nepafenac 0.1% (Nevanac) in Patients Undergoing Phacoemulsification

2007 · Frank A. Bucci, L. David Waterbury, et al. · American Journal of Ophthalmology · 39

Antimicrobial Efficacy of Prophylactic Gatifloxacin 0.3% and Moxifloxacin 0.5% in Patients Undergoing Phacoemulsification Surgery

2007 · Frank A. Bucci, Loretta M. Amico, et al. · Eye & Contact Lens Science & Clinical Practice · 24

The Effect of Preop Lid Scrubs and Levofloxacin on Eyelid and Conjunctival Cultures Prior to Cataract Surgery

2003 · Frank A. Bucci, L.M. Amico, et al. · Investigative Ophthalmology & Visual Science · 6

Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery

2015 · Frank Bucci, Jr., Timothy W. Morris, et al. · Clinical ophthalmology · 5

Comparison of Ketorolac 0.5%, Ketorolac 0.4%, and Diclofenac 0.1% – Combined With Prednisolone 0.1% on Aqueous Flare Following Cataract Surgery

2005 · Frank A. Bucci, Ruth Evans, et al. · Investigative Ophthalmology & Visual Science · 4

Aqueous PGE2 Inhibition of Ketorolac Tromethamine 0.45%, Bromfenac 0.09%, and Nepafenac 0.1% in Patients Undergoing Phacoemulsification

2010 · Frank A. Bucci, D. Waterbury, et al. · Investigative Ophthalmology & Visual Science · 3

Aqueous Penetration of Ketorolac 0.4% Compared With Bromfenac 0.09% in Cataract Patients: Peak and Trough Drug Concentrations

2007 · L.M. Amico, Frank A. Bucci, et al. · Investigative Ophthalmology & Visual Science · 2

Efficacy of Ketorolac 0.5% versus Ketorolac 0.4% Following Cataract Surgery

2005 · Ruth Evans, Frank A. Bucci, et al. · Investigative Ophthalmology & Visual Science · 1

Antibacterial Susceptibility of Coagulase Negative Staph Before and After Prophylactic Use of Besifloxacin and Moxifloxacin

2014 · Frank A. Bucci, Christine M. Sanfilippo, et al. · Investigative Ophthalmology & Visual Science

Aqueous PGE2 Inhibition of Ketorolac 0.4% vs. Nepafenac 0.1% in Patients Undergoing Phacoemulsification

2006 · L.M. Amico, Frank A. Bucci, et al. · Investigative Ophthalmology & Visual Science

Works count: 10

Citation count: 84

H-index: 4

I10-index: 2